AB-3144F

TRIAL LEADER IS DEFICIENT

Martin Landray speaks of HCQ doses used in Oxford Recovery Trial

COVID

Hydroxychloroquine

AB-3144E

TRIAL LEADER EXPLAINS

INTERVIEW EXCLUSIVE : Martin Landray, Recovery - hydroxychloroquine game over UK

COVID

Hydroxychloroquine